Literature DB >> 20209499

Cytoplasmic accumulation of connexin32 expands cancer stem cell population in human HuH7 hepatoma cells by enhancing its self-renewal.

Yohei Kawasaki1, Yasufumi Omori, Qingchang Li, Yuji Nishikawa, Toshiaki Yoshioka, Masayuki Yoshida, Kazuo Ishikawa, Katsuhiko Enomoto.   

Abstract

Although the connexin32 (Cx32)-mediated gap junction is abolished in hepatocellular carcinoma (HCC), the expression of cytoplasmic Cx32 tends to increase in correspondence with the grade of malignancy. Establishing a Tet-off expression system in human nonmetastatic HuH7 HCC cells where cytoplasmic Cx32 was overexpressed by doxycycline (Dox) withdrawal, we previously demonstrated that overexpression of cytoplasmic Cx32 made HuH7 cells metastatic in mice. In our study, hypothesizing that the cytoplasmic Cx32-induced metastasis may involve expansion of the cancer stem cell (CSC) population, we examined whether cytoplasmic Cx32 controlled the size of the side population (SP) in HuH7 Tet-off Cx32 cells. Fluorescence-activated cell sorting revealed that SP was expanded in a Dox-free medium compared with a Dox-supplemented one. Although cytoplasmic Cx32 did not block maturation from SP to non-SP, purified SP reconstituted a larger SP fraction in the Dox-free medium than in the Dox-supplemented one. Furthermore, although SP from HuH7 Tet-off mock cells formed a similar number of CSC spheres of a similar size whether with or without Dox, SP from HuH7 Tet-off Cx32 cells developed a greater number of larger CSC spheres in the Dox-free medium than in the Dox-supplemented one. Taken together, these results suggest that accumulation of cytoplasmic Cx32 should enhance self-renewal of CSC to expand the CSC population in HCC.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20209499     DOI: 10.1002/ijc.25308

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

Review 1.  Gap junctions and cancer: communicating for 50 years.

Authors:  Trond Aasen; Marc Mesnil; Christian C Naus; Paul D Lampe; Dale W Laird
Journal:  Nat Rev Cancer       Date:  2016-10-21       Impact factor: 60.716

2.  Ideal sphere-forming culture conditions to maintain pluripotency in a hepatocellular carcinoma cell lines.

Authors:  Seon Ok Min; Sang Woo Lee; Seon Young Bak; Kyung Sik Kim
Journal:  Cancer Cell Int       Date:  2015-10-09       Impact factor: 5.722

Review 3.  The malignant social network: cell-cell adhesion and communication in cancer stem cells.

Authors:  James S Hale; Meizhang Li; Justin D Lathia
Journal:  Cell Adh Migr       Date:  2012-07-01       Impact factor: 3.405

Review 4.  Connexin and pannexin signaling in gastrointestinal and liver disease.

Authors:  Michaël Maes; Sara Crespo Yanguas; Joost Willebrords; Bruno Cogliati; Mathieu Vinken
Journal:  Transl Res       Date:  2015-05-16       Impact factor: 7.012

5.  Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition.

Authors:  Yan Yang; Shu-Kui Qin; Qiong Wu; Zi-Shu Wang; Rong-Sheng Zheng; Xu-Hui Tong; Hao Liu; Liang Tao; Xian-Di He
Journal:  Oncol Rep       Date:  2013-12-05       Impact factor: 3.906

6.  PBX1 attributes as a determinant of connexin 32 downregulation in Helicobacter pylori-related gastric carcinogenesis.

Authors:  Xiao-Ming Liu; Can-Xia Xu; Lin-Fang Zhang; Li-Hua Huang; Ting-Zi Hu; Rong Li; Xiu-Juan Xia; Lin-Yong Xu; Ling Luo; Xiao-Xia Jiang; Ming Li
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

7.  Connexin30.3 is expressed in mouse embryonic stem cells and is responsive to leukemia inhibitory factor.

Authors:  Mikako Saito; Yuma Asai; Keiichi Imai; Shoya Hiratoko; Kento Tanaka
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

Review 8.  Connexins in cancer: bridging the gap to the clinic.

Authors:  Trond Aasen; Edward Leithe; Sheila V Graham; Petra Kameritsch; María D Mayán; Marc Mesnil; Kristin Pogoda; Arantxa Tabernero
Journal:  Oncogene       Date:  2019-02-27       Impact factor: 9.867

Review 9.  Cancer stem cell targeted therapy: progress amid controversies.

Authors:  Tao Wang; Sarah Shigdar; Michael P Gantier; Yingchun Hou; Li Wang; Yong Li; Hadi Al Shamaileh; Wang Yin; Shu-Feng Zhou; Xinhan Zhao; Wei Duan
Journal:  Oncotarget       Date:  2015-12-29

10.  Intrinsic Oncogenic Function of Intracellular Connexin26 Protein in Head and Neck Squamous Cell Carcinoma Cells.

Authors:  Nobuko Iikawa; Yohei Yamamoto; Yohei Kawasaki; Aki Nishijima-Matsunobu; Maya Suzuki; Takechiyo Yamada; Yasufumi Omori
Journal:  Int J Mol Sci       Date:  2018-07-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.